Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2600)	9/22/2009 3:20:41 PM
From: Jibacoa	of 3722

OPTR is trying again to test the resistance from the $14 to the $15 level.<g> The stock is still above $14, up 1.96% on moderate volume just above half its ADV. bigcharts.marketwatch.com OPTR reported substantially better revenues on its 2ndQ, but the loss was larger.The EL for this Yr is around $1.50 vs. $1.24 in 2008 It has negligible LTD, but has large negative CF Last week it announced new data from its PIII in which it highlighted fidaxomicin's (OPT-80) lower CDI recurrence rates and that it reduced risk of vancomycin-resistant enterococci acquisition. The data was presented at the 49th ICAAC in Frisco. Back in April it said that it plans to file an accelerated NDA for the drug to the EMEA The stock has had a good move from its Dec L at $3.30 On July 29 it made an all time H at $15.17 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next